Preoperative Metformin Tied to Better Surgical Outcomes

Risks for postop mortality, readmission down among adults with T2DM who received preop metformin

hospital bed

WEDNESDAY, April 15, 2020 (HealthDay News) -- Preoperative metformin prescriptions may be associated with decreased postoperative mortality and readmission among patients with diabetes undergoing a major surgical procedure, according to a study published online April 8 in JAMA Surgery.

Katherine M. Reitz, M.D., from the University of Pittsburgh School of Medicine, and colleagues used electronic health record data to identify 10,088 adults with diabetes who underwent a major operation with hospital admission (January 2010 to January 2016) at 15 community and academic hospitals within one health care system. Fifty-nine percent had preoperative metformin prescriptions. The analysis included 5,460 propensity score-matched patients (mean age, 67.7 years; 53 percent women).

The researchers found that in the propensity score-matched cohort, preoperative metformin was associated with a reduced hazard for 90-day mortality (adjusted hazard ratio [HR], 0.72 [95 percent confidence interval (CI), 0.55 to 0.95]; absolute risk reduction [ARR], 1.28 percent [95 percent CI, 0.26 to 2.31]) and hazard of readmission at 30 days (ARR, 2.09 percent [95 percent CI, 0.35 to 3.82]; sub-HR, 0.84 [95 percent CI, 0.72 to 0.98]) and 90 days (ARR, 2.78 percent [95 percent CI, 0.62 to 4.95]; sub-HR, 0.86 [95 percent CI, 0.77 to 0.97]). Preoperative inflammation was lower in those with metformin prescriptions versus those without (mean neutrophil-to-leukocyte ratio, 4.5 [95 percent CI, 4.3 to 4.6] versus 5.0 [95 percent CI, 4.8 to 5.3]).

"The advantages are likely not disease specific, but instead the pleiotropic properties may modulate the stress response generated by a major surgical intervention or confer consistently good outcomes, regardless of the surgical procedure," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing

Published on April 15, 2020

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ